Literature DB >> 12772779

Gene therapy for cancer: current status and prospects.

Gregory P Kouraklis.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12772779     DOI： 10.1023/a:1023026907848

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  Gene transfer technology in therapy: current applications and future goals.

Authors:  G Romano; C Pacilio; A Giordano
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

2.  New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet.

Authors:  T Ochiya; Y Takahama; S Nagahara; Y Sumita; A Hisada; H Itoh; Y Nagai; M Terada
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

3.  Instability of adenoviral vectors during transport and its implication for clinical studies.

Authors:  C Nyberg-Hoffman; E Aguilar-Cordova
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

4.  Gene Therapy Advisory Committee. Report on the potential use of gene therapy in utero. Health Departments of the United Kingdom, November 1998.

Authors: 
Journal:  Hum Gene Ther       Date:  1999-03-01       Impact factor: 5.695

Review 5.  Global gene and cell replacement strategies via stem cells.

Authors:  K I Park; J Ourednik; V Ourednik; R M Taylor; K S Aboody; K I Auguste; M B Lachyankar; D E Redmond; E Y Snyder
Journal:  Gene Ther       Date:  2002-05       Impact factor: 5.250

6.  High-efficiency transfer of cystic fibrosis transmembrane conductance regulator cDNA into cystic fibrosis airway cells in culture using lactosylated polylysine as a vector.

Authors:  W J Kollen; A E Mulberg; X Wei; M Sugita; V Raghuram; J Wang; J K Foskett; M C Glick; T F Scanlin
Journal:  Hum Gene Ther       Date:  1999-03-01       Impact factor: 5.695

Review 7.  Progress in cancer gene therapy.

Authors:  G Kouraklis
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

Review 8.  Gene therapy for cancer: what have we done and where are we going?

Authors:  J A Roth; R J Cristiano
Journal:  J Natl Cancer Inst       Date:  1997-01-01       Impact factor: 13.506

9.  Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

Authors:  K Roy; H Q Mao; S K Huang; K W Leong
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

Review 10.  Gene therapy for cancer: from the laboratory to the patient.

Authors:  G Kouraklis
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.487
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.